Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Pollak (2007)
Insulin-like growth factor-related signaling and cancer development.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 174
A. Singhi, W. Westra (2010)
Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experienceCancer, 116
Mitsuhiro Nakamura, J. Bodily, Melanie Beglin, Satoru Kyo, Masaki Inoue, L. Laimins (2009)
Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.Virology, 387 2
D. Sachdev, D. Yee (2007)
Disrupting insulin-like growth factor signaling as a potential cancer therapyMolecular Cancer Therapeutics, 6
K. Ang, J. Harris, R. Wheeler, R. Weber, David Rosenthal, P. Nguyen-Tan, William Westra, Christine Chung, Richard Jordan, Charles Lu, Harold Kim, R. Axelrod, C. Silverman, Kevin Redmond, Maura Gillison (2010)
Human papillomavirus and survival of patients with oropharyngeal cancer.The New England journal of medicine, 363 1
M. Serrano, M. Sanchez-Gomez, M. Bravo, S. Yakar, D. Leroith (2008)
Differential Expression of IGF-I and Insulin Receptor Isoforms in HPV Positive and Negative Human Cervical Cancer Cell LinesHormone and Metabolic Research, 40
A. Gentile, L. Trusolino, P. Comoglio (2008)
The Met tyrosine kinase receptor in development and cancerCancer and Metastasis Reviews, 27
E. Córdova-Alarcón, Federico Centeno, J. Reyes-Esparza, A. García-Carrancá, E. Garrido (2005)
Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line.Archives of medical research, 36 4
L. Coussens, D. Hanahan, J. Arbeit (1996)
Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice.The American journal of pathology, 149 6
I. Kuzmin, Limin Liu, R. Dammann, L. Geil, E. Stanbridge, S. Wilczynski, M. Lerman, G. Pfeifer (2003)
Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.Cancer research, 63 8
L. Sciacca, A. Costantino, G. Pandini, R. Mineo, F. Frasca, P. Scalia, P. Sbraccia, I. Goldfine, R. Vigneri, A. Belfiore (1999)
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanismOncogene, 18
J. DiPaolo, C. Woodworth, N. Popescu, V. Notario, J. Doniger (1989)
Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras.Oncogene, 4 4
Philippa O'Brien, M. Campo (2002)
Evasion of host immunity directed by papillomavirus-encoded proteins.Virus research, 88 1-2
M. Sklar (1988)
The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation.Science, 239 4840
D. Ekwueme, H. Chesson, Kevin Zhang, A. Balamurugan (2008)
Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis—United States, 2003Cancer, 113
G. Junior, F. Puglisi, E. Azambuja, N. Saghir, A. Awada (2006)
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm).Critical reviews in oncology/hematology, 59 1
A. Kersemaekers, G. Fleuren, G. Kenter, L. Broek, S. Uljee, J. Hermans, M. Vijver (1999)
Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 3
C. Ferreira, F. Erlich, C. Carmo, C. Viégas, I. Cidade, C. Camisão, I. Small, K. Fontão, R. Martins, A. Rodrigues (2008)
Erlotinib (E) combined with cisplatin (C) and radiotherapy (RT) for patients with locally advanced squamous cell cervical cancer: A phase II trialJournal of Clinical Oncology, 26
S. Syrjänen (2004)
HPV infections and tonsillar carcinomaJournal of Clinical Pathology, 57
W. Chen, F. Li, L. Mead, H. White, J. Walker, D. Ingram, A. Roman (2007)
Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.Virology, 367 1
K. Rajalingam, R. Schreck, U. Rapp, S. Albert (2007)
Ras oncogenes and their downstream targets.Biochimica et biophysica acta, 1773 8
Y. Cohen, G. Singer, O. Lavie, S. Dong, U. Beller, D. Sidransky (2003)
The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 8
M. Landro, D. Dalbert, M. Picconi, N. Cúneo, J. González, S. Vornetti, G. Bazán, J. Mural, J. Basiletti, A. Teyssié, L. Alonio (2008)
Human papillomavirus and mutated H‐ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: A retrospective follow‐upJournal of Medical Virology, 80
I. Mammas, A. Zafiropoulos, E. Koumantakis, S. Sifakis, D. Spandidos (2004)
Transcriptional activation of H- and N-ras oncogenes in human cervical cancer.Gynecologic oncology, 92 3
Kuichun Zhu, A. Hamilton, S. Sebti (2003)
Farnesyltransferase inhibitors as anticancer agents: current status.Current opinion in investigational drugs, 4 12
David Gaffney, D. Haslam, A. Tsodikov, E. Hammond, J. Seaman, J. Holden, R. Lee, K. Zempolich, M. Dodson (2003)
Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.International journal of radiation oncology, biology, physics, 56 4
Steven Fausch, Laura Fahey, D. Silva, W. Kast (2005)
Human Papillomavirus Can Escape Immune Recognition through Langerhans Cell Phosphoinositide 3-Kinase Activation1The Journal of Immunology, 174
D. Plas, C. Thompson (2005)
Akt-dependent transformation: there is more to growth than just survivingOncogene, 24
T. Imamura, H. Kikuchi, M. Herraiz, D. Park, Y. Mizukami, Mari Mino-Kenduson, M. Lynch, B. Rueda, Yair Benita, R. Xavier, D. Chung (2009)
HIF‐1α and HIF‐2α have divergent roles in colon cancerInternational Journal of Cancer, 124
M. Béquet-Romero, O. López-Ocejo (2000)
Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins.Biochemical and biophysical research communications, 277 1
Sokbom Kang, Hy-Sook Kim, S. Seo, Sang-Yoon Park, D. Sidransky, S. Dong (2007)
Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma.Gynecologic oncology, 105 3
L. Alonio, M. Picconi, D. Dalbert, J. Mural, O. Bartt, G. Bazán, M. Dominguez, A. Teyssié (2003)
Ha-ras oncogene mutation associated to progression of papillomavirus induced lesions of uterine cervix.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 27 3
B. Bertelsen, S. Steine, R. Sandvei, A. Molven, O. Laerum (2006)
Molecular analysis of the PI3K‐AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylationInternational Journal of Cancer, 118
K. Smith-McCune, N. Weidner (1994)
Demonstration and characterization of the angiogenic properties of cervical dysplasia.Cancer research, 54 3
Leri Faried, A. Faried, T. Kanuma, H. Aoki, T. Sano, Tomoko Nakazato, T. Tamura, H. Kuwano, T. Minegishi (2008)
Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapyMolecular Carcinogenesis, 47
Se-Heon Kim, B. Koo, Suki Kang, Kyeongmee Park, Haeryoung Kim, Kyung Lee, Moo-Joo Lee, Jong Kim, E. Choi, N. Cho (2007)
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c‐myc during tumor formationInternational Journal of Cancer, 120
Robert Brown, Ping Zhang, M. Lun, Shaobo Zhu, P. Pellitteri, Waldemar Riefkohl, A. Law, G. Wood, T. Kennedy (2006)
Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.Annals of clinical and laboratory science, 36 3
Matthias Dürst, D. Gallahan, G. Jay, J. Rhim (1989)
Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene.Virology, 173 2
H. Hausen (2009)
Papillomaviruses in the causation of human cancers - a brief historical account.Virology, 384 2
G. Clifford, S. Gallus, R. Herrero, N. Muñoz, P. Snijders, S. Vaccarella, P. Anh, C. Ferreccio, N. Hieu, E. Matos, M. Molano, R. Rajkumar, G. Ronco, de Sanjose, H-R Shin, S. Sukvirach, Jaiye Thomas, S. Tunsakul, C. Meijer, S. Franceschi (2005)
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisThe Lancet, 366
J. Karlson, A. Borg-Karlson, R. Unelius, M. Shoshan, N. Wilking, U. Ringborg, S. Linder (1996)
Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of actionAnti-Cancer Drugs, 7
F. Walker, S. Kermorgant, E. Daraï, P. Madélénat, A. Crémieux, D. Henin, T. Lehy (2003)
Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 1
Tony Gutschner, S. Diederichs (2012)
The hallmarks of cancerRNA Biology, 9
J. Wright, D. Viviano, M. Powell, R. Gibb, D. Mutch, P. Grigsby, J. Rader (2006)
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.Gynecologic oncology, 103 2
Yan Li, M. Nichols, J. Shay, Y. Xiong (1994)
Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.Cancer research, 54 23
F. Cutts, S. Franceschi, S. Goldie, X. Castellsagué, S. Sanjose, G. Garnett, W. Edmunds, P. Claeys, Kl Goldenthal, D. Harper, L. Markowitz (2007)
Human papillomavirus and HPV vaccines: a review.Bulletin of the World Health Organization, 85 9
N. Muñoz, F. Bosch, S. Sanjosé, R. Herrero, X. Castellsagué, K. Shah, P. Snijders, C. Meijer (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer.The New England journal of medicine, 348 6
G. Kristensen, R. Holm, V. Abeler, C. Tropé (1996)
Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c‐erbB‐2 in early cervical squamous cell carcinoma: An immunohistochemical studyCancer, 78
B. Bachtiary, M. Schindl, R. Pötter, B. Dreier, T. Knocke, J. Hainfellner, R. Horvat, P. Birner (2003)
Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 9 6
R. Schilder, M. Sill, Yi-Chun Lee, R. Mannel (2009)
A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group StudyInternational Journal of Gynecologic Cancer, 19
Courtney Granville, R. Memmott, Joell Gills, P. Dennis (2006)
Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin PathwayClinical Cancer Research, 12
E. Cutsem, H. Velde, P. Karásek, H. Oettle, W. Vervenne, A. Szawłowski, P. Schöffski, S. Post, C. Verslype, H. Neumann, H. Safran, Y. Humblet, J. Ruixo, Y. Ma, D. Hoff (2004)
Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 8
S. Sanjosé, Rosa Almirall, Belen Lloveras, Rebeca Font, Mireia Díaz, N. Muñoz, Isabel Català, C. Meijer, P. Snijders, Rolando Herrero, F. Bosch (2003)
Cervical Human Papillomavirus Infection in the Female Population in Barcelona, SpainSexually Transmitted Diseases, 30
B. Escudier, T. Eisen, W. Stadler, C. Szczylik, S. Oudard, M. Siebels, S. Négrier, C. Chevreau, E. Solska, A. Desai, F. Rolland, T. Demkow, Thomas Hutson, M. Gore, S. Freeman, B. Schwartz, M. Shan, R. Simantov, R. Bukowski (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma.The New England journal of medicine, 356 2
J. Walboomers, M. Jacobs, M. Manos, F. Bosch, J. Kummer, K. Shah, P. Snijders, J. Peto, C. Meijer, N. Muñoz (1999)
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 189
Esra Toussaint-Smith, D. Donner, A. Roman (2004)
Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factorsOncogene, 23
G. Zachos, D. Spandidos (1997)
Expression of ras proto-oncogenes: regulation and implications in the development of human tumors.Critical reviews in oncology/hematology, 26 2
H. Kiaris, D. Spandidos (1995)
Mutations of ras genes in human tumors (review).International journal of oncology, 7 3
E. Franco, L. Villa, J. Sobrinho, José Prado, M. Rousseau, M. Désy, T. Rohan (1999)
Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.The Journal of infectious diseases, 180 5
H. Hausen (2002)
Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2
M. Frisch, M. Goodman (2000)
Human papillomavirus‐associated carcinomas in Hawaii and the mainland U.S.Cancer, 88
J.-E. Kurtz, A. Hardy-Bessard, M. Deslandres, S. Lavau-Denès, R. Largillier, C. Roemer-Bécuwe, B. Weber, C. Guillemet, D. Paraiso, E. Pujade-Lauraine (2009)
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial.Gynecologic oncology, 113 1
D. Sabatini (2006)
mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 6
R. Dammann, Chun Li, J. Yoon, Philip Chin, S. Bates, G. Pfeifer (2000)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3Nature Genetics, 25
S. Charette, D. McCance (2007)
The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent mannerOncogene, 26
B. Monk, M. Sill, R. Burger, H. Gray, T. Buekers, L. Roman (2009)
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 7
Craig Menges, L. Baglia, R. Lapoint, D. McCance (2006)
Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein.Cancer research, 66 11
H. Hausen (2000)
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in CarcinogenesisJournal of the National Cancer Institute, 92
M. Vos, C. Ellis, A. Bell, M. Birrer, G. Clark (2000)
Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis*The Journal of Biological Chemistry, 275
D. Parkin, F. Bray (2006)
Chapter 2: The burden of HPV-related cancers.Vaccine, 24 Suppl 3
O. López-Ocejo, A. Viloria‐Petit, M. Béquet-Romero, D. Mukhopadhyay, J. Rak, R. Kerbel (2000)
Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent mannerOncogene, 19
C. Birchmeier, W. Birchmeier, E. Gherardi, G. Woude (2003)
Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 4
D. Brat, B. Kaur, Erwin Meir (2003)
Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors.Frontiers in bioscience : a journal and virtual library, 8
H. Trottier, E. Franco (2006)
The epidemiology of genital human papillomavirus infection.Vaccine, 24 Suppl 1
K. Münger, A. Baldwin, Kirsten Edwards, H. Hayakawa, Christine Nguyen, M. Owens, M. Grace, K. Huh (2004)
Mechanisms of Human Papillomavirus-Induced OncogenesisJournal of Virology, 78
H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, F. Kabbinavar (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.The New England journal of medicine, 350 23
E. Myers, D. Mccrory, D. Mccrory, Kavita Nanda, Lori Bastian, Lori Bastian, D. Matchar, D. Matchar (2000)
Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.American journal of epidemiology, 151 12
Leri Faried, A. Faried, T. Kanuma, Tomoko Nakazato, T. Tamura, H. Kuwano, T. Minegishi (2006)
Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.European journal of cancer, 42 7
The infection by the human papillomavirus (HPV) is the origin of several cancers around the world. In some areas of Brazil, cervical carcinoma is still the cancer with the highest incidence among women. After epithelial cell transformation by HPV, several molecular events are observed, resulting in the malignant phenotype. In this review we discuss potential molecular targets for therapeutic interventions in human HPV-related carcinomas, with emphasis on cervical cancer, based on the alterations observed in the signaling transduction pathways caused by HPV infection. With a special attention to tyrosine kinase receptors, and other kinases involved in signal transduction and angiogenesis, these pathological alterations are evaluated as novel targets for anticancer therapies in HPV-related carcinomas.
Oncology Reports – Spandidos Publications
Published: Dec 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.